<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref-53">
 <label>53</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Nell</surname>
    <given-names>AS</given-names>
   </name>
   <name>
    <surname>Dâ€™lom</surname>
    <given-names>E</given-names>
   </name>
   <name>
    <surname>Bouic</surname>
    <given-names>P</given-names>
   </name>
   <etal/>
  </person-group>: 
  <article-title>Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection.</article-title>
  <source>
   <italic>PLoS One.</italic>
  </source>
  <year>2014</year>;
  <volume>9</volume>(
  <issue>2</issue>):
  <fpage>e89612</fpage>. 
  <pub-id pub-id-type="doi">10.1371/journal.pone.0089612</pub-id>
  <!--<pub-id pub-id-type="pmcid">3935928</pub-id>-->
  <?supplied-pmid 24586912?>
  <pub-id pub-id-type="pmid">24586912</pub-id>
 </mixed-citation>
</ref>
